Skip to main content
Erschienen in: World Journal of Surgery 5/2020

01.05.2020 | Original Scientific Report

The Association Between Chronic Lymphocytic Thyroiditis and the Progress of Papillary Thyroid Cancer

verfasst von: Inhwa Lee, Hyeung Kyoo Kim, Euy Young Soh, Jeonghun Lee

Erschienen in: World Journal of Surgery | Ausgabe 5/2020

Einloggen, um Zugang zu erhalten

Abstract

Background

Whether chronic lymphocytic thyroiditis (CLT) influences the risk of development and the progression of papillary thyroid cancer (PTC) remains uncertain. We investigated the effects of CLT on the clinicopathologic features and prognosis of PTC.

Methods

Two thousand nine hundred twenty-eight consecutive patients with PTC treated between 2009 and 2017 were divided into two groups: one with chronic lymphocytic thyroiditis and one without; 1174 (40%) of the patients had coincident CLT.

Results

In univariate analysis, CLT correlated positively with small tumor size, frequent extrathyroidal extension, multifocal diseases, and p53 but negatively with central lymph node (LN) metastasis and BRAF mutation. In multivariate analysis, CLT was associated with extrathyroidal extension and multifocal disease; however, it was not a prognostic factor for recurrence even though it was associated with two aggressive factors. Compared with patients with PTC alone, there were more retrieved central LNs in the PTC + CLT group, and these patients also underwent more invasive diagnostic tests such as fine needle aspiration cytology and frozen biopsy of LN.

Conclusions

The CLT patients with PTC had better behavior features and prognoses than did those with PTC alone despite frequent multifocality and extrathyroidal extension. However, precaution may be necessary to avoid performing invasive diagnostic procedures for lateral LN metastasis and to manage the patients appropriately.
Literatur
1.
Zurück zum Zitat Parkin DM, Bray F, Ferlay J et al (2005) Global cancer statistics, 2002. CA Cancer J Clin 55:74–108CrossRef Parkin DM, Bray F, Ferlay J et al (2005) Global cancer statistics, 2002. CA Cancer J Clin 55:74–108CrossRef
2.
Zurück zum Zitat Albores-Saavedra J, Henson DE, Glazer E et al (2007) Changing patterns in the incidence and survival of thyroid cancer with follicular phenotype—papillary, follicular, and anaplastic: a morphological and epidemiological study. Endocr Pathol 18:1–7CrossRef Albores-Saavedra J, Henson DE, Glazer E et al (2007) Changing patterns in the incidence and survival of thyroid cancer with follicular phenotype—papillary, follicular, and anaplastic: a morphological and epidemiological study. Endocr Pathol 18:1–7CrossRef
3.
Zurück zum Zitat Consorti F, Loponte M, Milazzo F et al (2010) Risk of malignancy from thyroid nodular disease as an element of clinical management of patients with Hashimoto's thyroiditis. Eur Surg Res 45:333–337CrossRef Consorti F, Loponte M, Milazzo F et al (2010) Risk of malignancy from thyroid nodular disease as an element of clinical management of patients with Hashimoto's thyroiditis. Eur Surg Res 45:333–337CrossRef
4.
Zurück zum Zitat Repplinger D, Bargren A, Zhang YW et al (2008) Is Hashimoto's thyroiditis a risk factor for papillary thyroid cancer? J Surg Res 150:49–52CrossRef Repplinger D, Bargren A, Zhang YW et al (2008) Is Hashimoto's thyroiditis a risk factor for papillary thyroid cancer? J Surg Res 150:49–52CrossRef
5.
Zurück zum Zitat Pearce EN, Farwell AP, Braverman LE (2003) Thyroiditis. N Engl J Med 348:2646–2655CrossRef Pearce EN, Farwell AP, Braverman LE (2003) Thyroiditis. N Engl J Med 348:2646–2655CrossRef
6.
Zurück zum Zitat Jankovic B, Le KT, Hershman JM (2013) Clinical review: Hashimoto's thyroiditis and papillary thyroid carcinoma: is there a correlation? J Clin Endocrinol Metab 98:474–482CrossRef Jankovic B, Le KT, Hershman JM (2013) Clinical review: Hashimoto's thyroiditis and papillary thyroid carcinoma: is there a correlation? J Clin Endocrinol Metab 98:474–482CrossRef
7.
Zurück zum Zitat Gorges R, Maniecki M, Jentzen W et al (2005) Development and clinical impact of thyroglobulin antibodies in patients with differentiated thyroid carcinoma during the first 3 years after thyroidectomy. Eur J Endocrinol 153:49–55CrossRef Gorges R, Maniecki M, Jentzen W et al (2005) Development and clinical impact of thyroglobulin antibodies in patients with differentiated thyroid carcinoma during the first 3 years after thyroidectomy. Eur J Endocrinol 153:49–55CrossRef
8.
Zurück zum Zitat Tozzoli R, Bizzaro N, Tonutti E et al (2002) Immunoassay of anti-thyroid autoantibodies: high analytical variability in second generation methods. Clin Chem Lab Med 40:568–573CrossRef Tozzoli R, Bizzaro N, Tonutti E et al (2002) Immunoassay of anti-thyroid autoantibodies: high analytical variability in second generation methods. Clin Chem Lab Med 40:568–573CrossRef
9.
Zurück zum Zitat Bhatia A, Rajwanshi A, Dash RJ et al (2007) Lymphocytic thyroiditis—is cytological grading significant? A correlation of grades with clinical, biochemical, ultrasonographic and radionuclide parameters. CytoJournal 4:10CrossRef Bhatia A, Rajwanshi A, Dash RJ et al (2007) Lymphocytic thyroiditis—is cytological grading significant? A correlation of grades with clinical, biochemical, ultrasonographic and radionuclide parameters. CytoJournal 4:10CrossRef
10.
Zurück zum Zitat Bohuslavizki KH, vom Baur E, Weger B et al (2000) Evaluation of chemiluminescence immunoassays for detecting thyroglobulin (Tg) and thyroid peroxidase (TPO) autoantibodies using the IMMULITE 2000 system. Clin Lab 46:23–31PubMed Bohuslavizki KH, vom Baur E, Weger B et al (2000) Evaluation of chemiluminescence immunoassays for detecting thyroglobulin (Tg) and thyroid peroxidase (TPO) autoantibodies using the IMMULITE 2000 system. Clin Lab 46:23–31PubMed
11.
Zurück zum Zitat Sapin R, d'Herbomez M, Gasser F et al (2003) Increased sensitivity of a new assay for anti-thyroglobulin antibody detection in patients with autoimmune thyroid disease. Clin Biochem 36:611–616CrossRef Sapin R, d'Herbomez M, Gasser F et al (2003) Increased sensitivity of a new assay for anti-thyroglobulin antibody detection in patients with autoimmune thyroid disease. Clin Biochem 36:611–616CrossRef
12.
Zurück zum Zitat La'ulu SL, Slev PR, Roberts WL (2007) Performance characteristics of 5 automated thyroglobulin autoantibody and thyroid peroxidase autoantibody assays. Clin Chim Acta 376:88–95CrossRef La'ulu SL, Slev PR, Roberts WL (2007) Performance characteristics of 5 automated thyroglobulin autoantibody and thyroid peroxidase autoantibody assays. Clin Chim Acta 376:88–95CrossRef
13.
Zurück zum Zitat Lai X, Xia Y, Zhang B et al (2017) A meta-analysis of Hashimoto's thyroiditis and papillary thyroid carcinoma risk. Oncotarget 8:62414–62424PubMedPubMedCentral Lai X, Xia Y, Zhang B et al (2017) A meta-analysis of Hashimoto's thyroiditis and papillary thyroid carcinoma risk. Oncotarget 8:62414–62424PubMedPubMedCentral
14.
Zurück zum Zitat Brierley JD, Gospodarowicz MK, Wittekind C (eds) (2017) TNM classification of malignant tumours, 8th edn. Wiley, Hoboken Brierley JD, Gospodarowicz MK, Wittekind C (eds) (2017) TNM classification of malignant tumours, 8th edn. Wiley, Hoboken
15.
Zurück zum Zitat Tomari S, Watanabe M, Inoue N et al (2017) The polymorphisms in the thyroid peroxidase gene were associated with the development of autoimmune thyroid disease and the serum levels of anti-thyroid peroxidase antibody. Endocr J 64:1025–1032CrossRef Tomari S, Watanabe M, Inoue N et al (2017) The polymorphisms in the thyroid peroxidase gene were associated with the development of autoimmune thyroid disease and the serum levels of anti-thyroid peroxidase antibody. Endocr J 64:1025–1032CrossRef
16.
Zurück zum Zitat Iwatani Y, Amino N, Mori H et al (1983) T lymphocyte subsets in autoimmune thyroid diseases and subacute thyroiditis detected with monoclonal antibodies. J Clin Endocrinol Metab 56:251–254CrossRef Iwatani Y, Amino N, Mori H et al (1983) T lymphocyte subsets in autoimmune thyroid diseases and subacute thyroiditis detected with monoclonal antibodies. J Clin Endocrinol Metab 56:251–254CrossRef
17.
Zurück zum Zitat Asa SL (2004) My approach to oncocytic tumours of the thyroid. J Clin Pathol 57:225–232CrossRef Asa SL (2004) My approach to oncocytic tumours of the thyroid. J Clin Pathol 57:225–232CrossRef
18.
Zurück zum Zitat Vanderpump MP, Tunbridge WM, French JM et al (1995) The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham Survey. Clin Endocrinol (Oxf) 43:55–68CrossRef Vanderpump MP, Tunbridge WM, French JM et al (1995) The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham Survey. Clin Endocrinol (Oxf) 43:55–68CrossRef
19.
Zurück zum Zitat Liu Y, Li C, Zhao W et al (2017) Hashimoto's thyroiditis is an important risk factor of papillary thyroid microcarcinoma in younger adults. Horm Metab Res 49:732–738CrossRef Liu Y, Li C, Zhao W et al (2017) Hashimoto's thyroiditis is an important risk factor of papillary thyroid microcarcinoma in younger adults. Horm Metab Res 49:732–738CrossRef
20.
Zurück zum Zitat Zaydfudim V, Feurer ID, Griffin MR et al (2008) The impact of lymph node involvement on survival in patients with papillary and follicular thyroid carcinoma. Surgery 144:1070–1077 (discussion 1077–1078) CrossRef Zaydfudim V, Feurer ID, Griffin MR et al (2008) The impact of lymph node involvement on survival in patients with papillary and follicular thyroid carcinoma. Surgery 144:1070–1077 (discussion 1077–1078) CrossRef
21.
Zurück zum Zitat Yoo YH, Kim JA, Son EJ et al (2013) Sonographic findings predictive of central lymph node metastasis in patients with papillary thyroid carcinoma: influence of associated chronic lymphocytic thyroiditis on the diagnostic performance of sonography. J Ultrasound Med 32:2145–2151CrossRef Yoo YH, Kim JA, Son EJ et al (2013) Sonographic findings predictive of central lymph node metastasis in patients with papillary thyroid carcinoma: influence of associated chronic lymphocytic thyroiditis on the diagnostic performance of sonography. J Ultrasound Med 32:2145–2151CrossRef
22.
Zurück zum Zitat Babli S, Payne RJ, Mitmaker E et al (2018) Effects of chronic lymphocytic thyroiditis on the clinicopathological features of papillary thyroid cancer. Eur Thyroid J 7:95–101CrossRef Babli S, Payne RJ, Mitmaker E et al (2018) Effects of chronic lymphocytic thyroiditis on the clinicopathological features of papillary thyroid cancer. Eur Thyroid J 7:95–101CrossRef
23.
Zurück zum Zitat Zhu F, Shen YB, Li FQ et al (2016) The effects of Hashimoto thyroiditis on lymph node metastases in unifocal and multifocal papillary thyroid carcinoma: a retrospective Chinese cohort study. Medicine (Baltimore) 95:e2674CrossRef Zhu F, Shen YB, Li FQ et al (2016) The effects of Hashimoto thyroiditis on lymph node metastases in unifocal and multifocal papillary thyroid carcinoma: a retrospective Chinese cohort study. Medicine (Baltimore) 95:e2674CrossRef
24.
Zurück zum Zitat Yoon YH, Kim HJ, Lee JW et al (2012) The clinicopathologic differences in papillary thyroid carcinoma with or without co-existing chronic lymphocytic thyroiditis. Eur Arch Otorhinolaryngol 269:1013–1017CrossRef Yoon YH, Kim HJ, Lee JW et al (2012) The clinicopathologic differences in papillary thyroid carcinoma with or without co-existing chronic lymphocytic thyroiditis. Eur Arch Otorhinolaryngol 269:1013–1017CrossRef
25.
Zurück zum Zitat Girardi FM, Barra MB, Zettler CG (2015) Papillary thyroid carcinoma: does the association with Hashimoto's thyroiditis affect the clinicopathological characteristics of the disease? Braz J Otorhinolaryngol 81:283–287CrossRef Girardi FM, Barra MB, Zettler CG (2015) Papillary thyroid carcinoma: does the association with Hashimoto's thyroiditis affect the clinicopathological characteristics of the disease? Braz J Otorhinolaryngol 81:283–287CrossRef
26.
Zurück zum Zitat Del Rio P, Cataldo S, Sommaruga L et al (2008) The association between papillary carcinoma and chronic lymphocytic thyroiditis: does it modify the prognosis of cancer? Minerva Endocrinol 33:1–5PubMed Del Rio P, Cataldo S, Sommaruga L et al (2008) The association between papillary carcinoma and chronic lymphocytic thyroiditis: does it modify the prognosis of cancer? Minerva Endocrinol 33:1–5PubMed
27.
Zurück zum Zitat Liu Z, Wang L, Yi P et al (2014) Risk factors for central lymph node metastasis of patients with papillary thyroid microcarcinoma: a meta-analysis. Int J Clin Exp Pathol 7:932–937PubMedPubMedCentral Liu Z, Wang L, Yi P et al (2014) Risk factors for central lymph node metastasis of patients with papillary thyroid microcarcinoma: a meta-analysis. Int J Clin Exp Pathol 7:932–937PubMedPubMedCentral
28.
Zurück zum Zitat Asanuma K, Sugenoya A, Kasuga Y et al (1998) The relationship between multiple intrathyroidal involvement in papillary thyroid carcinoma and chronic non-specific thyroiditis. Cancer Lett 122:177–180CrossRef Asanuma K, Sugenoya A, Kasuga Y et al (1998) The relationship between multiple intrathyroidal involvement in papillary thyroid carcinoma and chronic non-specific thyroiditis. Cancer Lett 122:177–180CrossRef
29.
Zurück zum Zitat Ehlers M, Schott M (2014) Hashimoto's thyroiditis and papillary thyroid cancer: are they immunologically linked? Trends Endocrinol Metab 25:656–664CrossRef Ehlers M, Schott M (2014) Hashimoto's thyroiditis and papillary thyroid cancer: are they immunologically linked? Trends Endocrinol Metab 25:656–664CrossRef
30.
Zurück zum Zitat Giordano C, Stassi G, De Maria R et al (1997) Potential involvement of Fas and its ligand in the pathogenesis of Hashimoto's thyroiditis. Science 275:960–963CrossRef Giordano C, Stassi G, De Maria R et al (1997) Potential involvement of Fas and its ligand in the pathogenesis of Hashimoto's thyroiditis. Science 275:960–963CrossRef
31.
Zurück zum Zitat Han PA, Kim HS, Cho S et al (2016) Association of BRAF V600E mutation and microRNA expression with central lymph node metastases in papillary thyroid cancer: a prospective study from four endocrine surgery centers. Thyroid 26:532–542CrossRef Han PA, Kim HS, Cho S et al (2016) Association of BRAF V600E mutation and microRNA expression with central lymph node metastases in papillary thyroid cancer: a prospective study from four endocrine surgery centers. Thyroid 26:532–542CrossRef
32.
Zurück zum Zitat Ouyang B, Knauf JA, Smith EP et al (2006) Inhibitors of Raf kinase activity block growth of thyroid cancer cells with RET/PTC or BRAF mutations in vitro and in vivo. Clin Cancer Res 12:1785–1793CrossRef Ouyang B, Knauf JA, Smith EP et al (2006) Inhibitors of Raf kinase activity block growth of thyroid cancer cells with RET/PTC or BRAF mutations in vitro and in vivo. Clin Cancer Res 12:1785–1793CrossRef
33.
Zurück zum Zitat Kim SK, Song KH, Lim SD et al (2009) Clinical and pathological features and the BRAF(V600E) mutation in patients with papillary thyroid carcinoma with and without concurrent Hashimoto thyroiditis. Thyroid 19:137–141CrossRef Kim SK, Song KH, Lim SD et al (2009) Clinical and pathological features and the BRAF(V600E) mutation in patients with papillary thyroid carcinoma with and without concurrent Hashimoto thyroiditis. Thyroid 19:137–141CrossRef
34.
Zurück zum Zitat Muzza M, Degl'Innocenti D, Colombo C et al (2010) The tight relationship between papillary thyroid cancer, autoimmunity and inflammation: clinical and molecular studies. Clin Endocrinol (Oxf) 72:702–708CrossRef Muzza M, Degl'Innocenti D, Colombo C et al (2010) The tight relationship between papillary thyroid cancer, autoimmunity and inflammation: clinical and molecular studies. Clin Endocrinol (Oxf) 72:702–708CrossRef
Metadaten
Titel
The Association Between Chronic Lymphocytic Thyroiditis and the Progress of Papillary Thyroid Cancer
verfasst von
Inhwa Lee
Hyeung Kyoo Kim
Euy Young Soh
Jeonghun Lee
Publikationsdatum
01.05.2020
Verlag
Springer International Publishing
Erschienen in
World Journal of Surgery / Ausgabe 5/2020
Print ISSN: 0364-2313
Elektronische ISSN: 1432-2323
DOI
https://doi.org/10.1007/s00268-019-05337-9

Weitere Artikel der Ausgabe 5/2020

World Journal of Surgery 5/2020 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.